Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Carolina BioOncology Institute | Researchclopedia

Back to institutions

Carolina BioOncology Institute

Huntersville, North Carolinafacility

250

Works

27,949

Citations

55

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Monoclonal and Polyclonal Antibodies Research

Top Researchers

Drew M. Pardoll Bloomberg (United States)

889 works165,775 citationsh-index: 164

Recent Research

220eTiP A first-in-human, phase I study of XB010, a 5T4-MMAE ADC, in patients with non-small cell lung cancer (NSCLC) and other solid tumors

MA Salkeni,F.A. Larijani,et al.

20260 citations

Immunotherapy and Immune Responses

HER2/EGFR in Cancer Research

Radiopharmaceutical Chemistry and Applications

Peptidase Inhibition and Analysis

Cancer Genomics and Diagnostics

Immune Cell Function and Interaction

Lung Cancer Treatments and Mutations

Colorectal Cancer Treatments and Studies

Adenosine and Purinergic Signaling

F. Stephen Hodi Harvard University

1,522 works161,526 citationsh-index: 156

Arnold J. Levine Harvard University Press

645 works131,170 citationsh-index: 145

Julie R. Brahmer Bloomberg (United States)

822 works122,656 citationsh-index: 115

Jeffrey S. Weber NYU Langone Health

1,156 works97,808 citationsh-index: 122

Suzanne L. Topalian Bloomberg (United States)

360 works96,654 citationsh-index: 101

RNDO-564-001: A first-in-human, phase 1/1b study of RNDO-564, a bispecific antibody for the treatment of advanced bladder cancer and other tumors associated with Nectin-4 expression.

Benjamin Garmezy,Manpreet Kaur,et al.

20260 citations

Abstract PS1-12-27: Trends and Barriers in Biomarker Testing and Treatment Patterns in HR+/HER2- Metastatic Breast Cancer

I. M. Abbass,D. Lebovitch,et al.

20260 citations

Phase 1/2 study of ARV-806, a PROTAC KRAS G12D degrader, in <i>KRAS</i> G12D–mutated advanced solid tumors, including pancreatic cancer.

Yonina R. Murciano‐Goroff,P. Lorusso,et al.

20260 citations

EV0029 IMPROVED CLINICAL OUTCOMES FOLLOWING RADIOFREQUENCY ABLATION IN A PROSPECTIVE, MULTICENTER STUDY (RAPID): 24-MONTH OUTCOMES

D Provenzano,Kristine Houle,et al.

20260 citations

SmartFieldMesh: A Self-Healing IoT Mesh Network for Resilient Communication in Harsh Environments

20250 citations